In the no-CKD and stage 3a groups, the burden of antihypertensive medication remained high, but it declined in the CKD stage 3b group over three years. "RDN is likely to be safe and may represent an ...
Reductions seen in office systolic blood pressure for those in no-CKD, stage 3a CKD, and stage 3b CKD groups. (HealthDay News) — Radiofrequency renal denervation (RDN) yields a clinically meaningful ...
A high-risk cohort of beneficiaries with chronic kidney disease (CKD) stage 3 have a profile similar to patients with CKD stages 4 and 5, indicating potential benefit of earlier nephrology ...
Higher rheumatoid arthritis (RA) disease activity is associated with an accelerated kidney function decline and increased risk for chronic kidney disease (CKD) stages G3a and G3b. Higher RA disease ...
RADNOR, Pa., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results